A Collagen Hydrolysate Containing Tripeptides Ameliorates Sarcopenia in Middle-Aged Mice

Molecules. 2022 Apr 22;27(9):2718. doi: 10.3390/molecules27092718.

Abstract

Collagen peptide (CP) and collagen tripeptide (CTP) are supplementary health foods that exhibit several biological effects. However, the effects of collagen on age-associated sarcopenia and its underlying mechanisms are unclear. C57BL/6J mice (n = 24, 12 months old) were divided into three dietary groups and administered AIN93G (aging control, AC; JA BIO, Suwon, Korea), AIN93G plus 0.2% CP, and AING93G plus 0.2% CTP supplement for 12 weeks. The results indicated that the CP and CTP supplements significantly increased the weight of the quadriceps tibialis anterior and gastrocnemius muscles and reduced body fat. A morphological analysis revealed that the spaces within the muscle cells were tight with attenuated fibrosis following CP and CTP supplementation. Immunohistochemistry was applied and a Western blot analysis was performed to determine the underlying mechanisms. The CTP supplement increased the expression of IGF-1, PI3K/AKT, and mTOR, whereas the CP supplement increased the expression of IGF-1 and AMPK in the gastrocnemius of aging mice. CP and CTP ameliorate age-associated sarcopenia through different mechanisms.

Keywords: aging; collagen hydrolysate; collagen tripeptide; muscle loss; sarcopenia.

MeSH terms

  • Aging
  • Animals
  • Collagen / metabolism
  • Collagen Type I*
  • Insulin-Like Growth Factor I / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Skeletal / metabolism
  • Peptides / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Sarcopenia* / drug therapy
  • Sarcopenia* / metabolism

Substances

  • Collagen
  • Insulin-Like Growth Factor I
  • Peptides
  • Phosphatidylinositol 3-Kinases
  • Collagen Type I